Common Shares Outstanding: The number of class A shares currently held by investors.
Solid Biosciences Inc. (SLDB) had Common Shares Outstanding of 98.39M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-56.74M |
|
-- |
|
-- |
|
$57.31M |
|
$-57.31M |
|
$0.57M |
|
$-56.74M |
|
$-56.74M |
|
$-56.74M |
|
$-56.74M |
|
$-56.74M |
|
$-56.74M |
|
$-57.31M |
|
$-57.53M |
|
109.81M |
|
109.81M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$396.79M |
|
$3.91M |
|
$26.11M |
|
$422.89M |
|
$30.28M |
|
-- |
|
$18.48M |
|
$48.76M |
|
$374.13M |
|
$374.13M |
|
$374.13M |
|
|
Common Shares Outstanding |
98.39M |
| Cash Flow Statement Financials | |
$-47.23M |
|
$44.76M |
|
$239.03M |
|
$61.89M |
|
$298.44M |
|
$236.56M |
|
$5.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-47.40M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.16% |
|
-15.16% |
|
-13.42% |
|
-15.16% |
|
$3.80 |
|
$-0.43 |
|
$-0.43 |
|